A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Epigenetic markers of prostate cancer in plasma circulating DNA
2012
Human Molecular Genetics
Epigenetic differences are a common feature of many diseases, including cancer, and disease-associated changes have even been detected in bodily fluids. DNA modification studies in circulating DNA (cirDNA) may lead to the development of specific non-invasive biomarkers. To test this hypothesis, we investigated cirDNA modifications in prostate cancer patients with locally confined disease (n 5 19), in patients with benign prostate hyperplasias (n 5 20) and in men without any known prostate
doi:10.1093/hmg/dds192
pmid:22619380
fatcat:orbk2dtvcjfvtdhdbnwfo25zvm